Tuesday, November 28, 2023

Investor Ideas Potcasts: Interview with Kaya Holdings (OTCQB: $KAYS) on the Sacred Mushroom Center - Pioneers with Psilocybin and Advocates for Mental Health; @KayaHoldings

 





 

Investor Ideas Potcasts: Interview with Kaya Holdings (OTCQB: $KAYS) on the Sacred Mushroom Center - Pioneers with Psilocybin and Advocates for Mental Health; @KayaHoldings

 

November 28, 2023 (Investorideas.com Newswire), Investorideas.com, a global news source covering leading sectors including marijuana and psychedelic stocks releases a special edition of  the top rated Investor Ideas potcast (Cannabis Podcast).

 

In today’s episode, Investor Idea’s host Cali Van Zant speaks with CEO Craig Frank and Senior Consultant Dave Jones of Kaya Holdings Inc (OTCQB: KAYS).

 

Listen to the podcast:

https://www.investorideas.com/Audio/Podcasts/2023/112223-Cannabis.mp3

 

Read this in full at https://www.investorideas.com/news/2023/cannabis-potcasts/11281Interview-Kaya-Holdings.asp

 

Kaya Holdings, Inc. is a mind care company focusing on wellness and mental health through their operations in medical and recreational cannabis, CBD products and psychedelic treatment clinics.

 

Kaya has the historical distinction of being the first US publicly traded company to hold and operate cannabis licenses in “touch the plant” categories from when it commenced cannabis operations in Portland, Oregon in 2014.

 

In today’s podcast, management discusses the new opportunities in the medical psychedelic market and how Kaya Holdings is leading the way as an innovator and pioneer in the sector. They also talk about their recent milestone of opening one of the first state licensed Psilocybin Treatment Centers in the United States, in Portland, Oregon. 

 

Host Cali Van Zant says, “What makes this podcast special is to hear management go deep and share their personal experiences and show that they care about community. We discuss mental health and how it personally affects us all. It is a rare opportunity to get such personal insight from a management team and the opportunity to find a public company with heart. I hope you all enjoy listening and share this interview.”

 

To learn more about Kaya holdings you can visit their website at (www.kayaholdings.com) or reach out to the team at info@kayaholdings.com

 

Today’s podcast overview

 

When talking about the new Sacred Mushroom space, CEO Craig Frank notes, “It is very important to us that the facility be in a central location because we think community is a big part of the healing process. We were very lucky to find the perfect location.”

 

“The space is the entire top floor of the Falcon Building in downtown Portland. At about 11,000 square feet, we have the area we need to offer both private and group experiences, as well as creativity centers, sensory rooms, reflection areas, and the room to roam and explore. We are equipped with a full kitchen and will be able to provide food consistent with Oregon regulation….

 

I think there are four primary differences between us and what we have seen so far. I would say the first difference is the space itself. A huge contributing factor in the quality of an experience is the setting and ours is extraordinary. Another difference would be the extent to which we aim to cater the journey to individual preference, with sound, sight, and scent options and the activity options presented. Third, I would say the community we seek to create. While we will cater to out-of-state visitors, our emphasis is on serving the needs of the Greater Portland area. Finally, I would say our pricing model is different. We are aiming to enable sustained treatment to those who seek it, so we have some less expensive microdosing options.”

 

When talking about other companies in the psilocybin space, he went on to say, “The work of companies like ATAI Life Sciences (NASDAQ: ATAI) and Compass Pathways (NASDAQ:CMPS) is fascinating and we are excited to see what their research can teach all of us about the medicinal possibilities of psilocybin.

 

CMPS is developing its own synthetic versions of that they then plan to administer in their own treatment facilities. Our model calls for the use of natural psilocybin and psilocin in our own facilities.  We believe our model is more immediate and allows us to avoid the long, laborious, and very costly FDA process. We expect to begin offering treatments immediately upon licensing of our facility…”

 

When talking about the personal reasons for building a treatment center and working in the Psilocybin space, Frank says, “I would say that it is hard to find an American family that does not have someone with a mental disorder effecting their personal story whether it be a sibling, a parent, a child, or a friend. There is something in the way we live that causes profound pain and disorder in some people and our involvement is in some ways motivated to bring this relief; to those we love and those other people love.”

 

About Kaya Holdings, Inc. (www.kayaholdings.com )

Kaya Holdings, Inc is a "mind care" company with operations in medical/recreational cannabis and pending operations in the emerging psilocybin sector. KAYS is a fully reporting, US-based publicly traded company, listed for trading on the over-the-counter market under the symbol KAYS.

 

In 2014, KAYS became the first US public company to own and operate a medical cannabis dispensary (in Portland, Oregon). The Company still operates the original Kaya Shack™ cannabis dispensary while seeking to shift our cannabis operations to serve the European Union. KAYS has interests in three medical cannabis licenses (2 in Greece, 1 in Israel) to advance this effort.

 

Resuming its role as innovator and trend setter, the Company is again breaking ground in the United States with the planned introduction of psilocybin treatment centers through our majority owned subsidiary, Fifth Dimension Therapeutics, Inc. ("FDT").

 

About Investorideas.com - Big Investing Ideas

Investorideas.com is a platform for investing ideas. We publish breaking stock news, stock research, guest posts and create original top rated investing podcasts, plus sector tag articles featuring up and coming companies and industry leaders.  Investor Idea’s original branded content includes the Crypto Corner Podcast , Play by Play Sports Podcast , Cannabis News and Stocks on the Move Podcast ,  Cleantech and Climate Change Podcast,  Exploring Mining Podcast , Betting on Gaming Stocks Podcast and the AI Eye Podcast.  We also create free investor stock directories for AI and tech, biotech, cannabis, cleantech, crypto, defense, gaming, health and wellness, mining, oil and gas, sports and water.

 

To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.

The Investorideas.com podcasts are also available on iTunes (Apple Podcasts), Audible, Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio, Google Podcasts and most audio platforms available.

 

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure: KAYS is a paid for monthly featured stock on Investorideas.com. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.



Investorideas.com potcasts - Listen Daily to Investor Ideas Potcasts #Cannabis News and Stocks on the Move

 

Check out our stock directory of publicly traded CSE, TSX, TSXV, OTC, NASDAQ, NYSE, ASX Marijuana / Hemp Stocks plus the new psychedelic stock directory!

Follow Pot stocks news - Get News Alerts on Marijuana Stocks

 

Posted by at No comments:

Thursday, November 23, 2023

Is #AI Paving the way for #MentalHealth #Stocks? (CSE: $NARA.CN) (NASDAQ: $WAVD) (NYSE: $AMWL) (NASDAQ: $TALK) @pangenomic @Amwell @talkspace

Is #AI Paving the way for #MentalHealth #Stocks? (CSE: $NARA.CN) (NASDAQ: $WAVD) (NYSE: $AMWL) (NASDAQ: $TALK) @pangenomic @Amwell @talkspace

 

November 23, 2023 - Investorideas.com (www.investorideas.com), a global investor news source covering health and wellness stocks releases a special report on breakthrough technologies for mental health, featuring PanGenomic Health Inc. (CSE: NARA) (AQSE: NARA). PanGenomic describes itself as ‘’Your smart tech partner in natural health’ and is using the power of AI to help revolutionize healing. 

 

Read this article, featuring NARA in full at https://www.investorideas.com/news/2023/technology/11231AI-Mental-Health.asp

 

The global mental wellness market is anticipated to grow from USD 145.83 billion to USD 280.52 billion in 10 years. The market will experience rapid growth due to the rising awareness about mental wellness, Major market players are investing extensive capital in developing therapies, drugs, medical devices, equipment, systems, and treatments based on research findings to cater to the growing mental wellness market.

 

Most medical experts agree we are in a global mental health crisis and it is only worsening. While some companies turn to traditional methods including pharmaceuticals to solve the growing problem, others are looking to revolutionize the way we treat mental health using technology, and AI is aiming to take the driver’s seat.

 

PanGenomic Health Inc. (CSE: NARA) (AQSE: NARA), a precision health company that has developed a self-care digital platform using AI recently announced that its subsidiary, MUJN Diagnostics Inc. has launched its BDNF (brain-derived neurotrophic factor) mental health biomarker health assessment service.

 

More significantly, it has completed its first sale of the point-of-care test marketed to health clinics in Canada.

 

From the news: MUJN Diagnostics Inc. is a wholly-owned subsidiary of PanGenomic Health Inc. and is focused on developing a decision support system for alternative healthcare providers. MUJN's Decision Support System is intended to include biomarker diagnostics, symptom and treatment tracking, and personalized health analytics, with the goal of empowering healthcare providers and their patients towards better outcomes.

 

"Our strategy is to continue to expand MUJN Diagnostic's health services beyond our initial Vitamin D assessments to include rapid in-clinic access to a panel of mental health patient point-of-care biomarker assessments", said Vincent Lum, CEO of MUJN Diagnostics and Co-Founder of PanGenomic Health. "Our newest product is the MUJN BDNF Biomarker assessment for mental health and wellness. Changes in BDNF levels provide important information for health practitioners when considering treatment options for patients with brain health concerns such as major depressive disorder."

 

From the news: Current clinical research on BDNF has found that:

 

BDNF plays a significant role in the survival and development as well as creation of new neurons. BDNF has been shown to be a critical regulator of neurocognitive functions and impairment of BDNF levels have been connected to a variety of mental health diseases.

 

Decrease in the expression of BDNF is seen in many neurological problems such as Depression, Alzheimer's, Parkinson's, Huntington's and bipolar disease.

 

BDNF serum levels are lower in patients with major depressive disorder compared with those in healthy controls. Pharmacological treatments often lead to an increase in BDNF levels, which correlates with an improvement in a patient's mental health condition.

 

PanGenomic’s current ‘product line  includes its  Nustasis AI Platform, MUJN Diagnostics, and the NARA and MindLeap consumer apps, all designed to complement conventional medicine, and simplify the path to better health.

 

According to a June press release; “The Company is planning to launch Conversational AI on the web based NARA platform by Q3, followed by a roll out on the NARA app by Q4 of this year.”

 

A new entry to the public market with an AI approach to mental health, WaveDancer, Inc. (NASDAQ: WAVD)  announced last week that it has entered into a definitive merger agreement with privately held, commercial-stage, medical technology company, Firefly Neuroscience, Inc. (“Firefly”), to combine the companies in an all-stock transaction. The combined company will focus on continuing to develop and commercialize Firefly’s Artificial Intelligence driven Brain Network Analytics (BNA™) platform, which was previously cleared by the U.S. Food and Drug Administration (“FDA”). Upon closing, which is currently expected in Q1-2024, the combined company is expected to operate under the name Firefly Neuroscience, Inc., and trade on the Nasdaq Capital Market.

 

Describing  Firefly’s Brain Network Analytics (BNA™) platform the news says, “BNA™ is an FDA-cleared, cloud-based, AI-powered platform used to objectively assess brain function by comparing patient electroencephalograms (EEGs) with a proprietary database of standardized, high-definition EEGs and behavioral data. BNA™ is used by psychiatrists and neurologists in the United States to support the diagnosis of mental illnesses and cognitive disorders; optimize treatment care pathways; and improve patient compliance to therapy. Real-world clinical use has shown that when BNA™ is used as part of patient management, patients showed improved response rates; enhanced therapy compliance; and reduced non-responder rates and need for medication switching.”

 

From the news: Jamie Benoit, Chief Executive Officer and Chairman of WaveDancer, commented, “Following a strategic review and analysis of our long-term prospects as a publicly-traded company, the Board determined that this merger is in the best interests of WaveDancer’s stockholders and an attractive opportunity to realize significant value as Firefly pursues multiple market opportunities for its BNA™ platform. Firefly has emerged from the rigorous FDA approval process and its BNA™ platform has been subjected to comprehensive academic peer-review. We believe these factors contribute to a competitive advantage for Firefly and position it as a unique public company.”

 

Harnessing the power of AI for mental health improvement, Virtual care provider Amwell (NYSE: AMWL) as reported by Behavioral Health ”has its sights set on using artificial intelligence to bolster its behavioral health capabilities.”

 

“The telehealth giant recently launched a system within its platform that immediately connects patients to a therapist in real time.”

 

“After Amwell providers or its AI-backed automated systems determine the patient needs mental health services, the patient is queued to see a clinician on the same platform. The move is meant to bridge a systemic gap in health care: patient activation.”

 

“Amwell rolled out the system near the beginning of the quarter. It’s part of the company’s rolling implementation of Converge, a unified tech platform.”

 

“Survey data show that about 42% of Americans who sought mental health care couldn’t get it because of costs or other barriers, such as lack of proximity to care. This is a dire roadblock that keeps patients from getting the care they seek, or that is prescribed to them by primary care providers, who already have access to the patient.”

 

Also using technology for mental health, Talkspace (Nasdaq: TALK) a leading virtual behavioral healthcare company recently reported third quarter 2023 financial results.

 

Third Quarter 2023 Key Performance Metrics:

 

Revenue increased 32% over the prior-year period to $38.6 million, driven by a 79% year-over-year increase in the B2B revenue categories, partially offset by a 32% year-over-year consumer revenue decline.

 

Gross profit increased 29% over the prior-year period to $18.8 million, and gross margin declined to 48.8% from 49.8% year-over-year, driven by a shift in revenue mix towards payor.

Operating expenses were $24.0 million, down 30% year-over-year, driven by a reduction across all of our operating cost categories.

 

Net loss was $(4.4) million, an improvement from $(18.0) million net loss in the third quarter of 2022, primarily driven by lower operating expenses and an increase in revenues.

 

Talkspace pioneered the ability to text with a licensed therapist from anywhere and now offers a comprehensive suite of mental health services from self-guided products to individual and couples therapy, in addition to psychiatric treatment and medication management. With Talkspace’s core psychotherapy offering, members are matched with one of thousands of licensed providers across all 50 states and can choose from a variety of subscription plans including live video, text or audio chat sessions and/or asynchronous text messaging.

 

As technology evolves, the applications for health and wellness are endless. As PanGenomic Health says – AI and other technology may become natural health’s ‘smart tech partner’ of the future.

 

About Investorideas.com - Big Investing Ideas

Investorideas.com is a platform for investing ideas. We publish breaking stock news, stock research, guest posts and create original top rated investing podcasts, plus sector tag articles featuring up and coming companies and industry leaders.  Investor Idea’s original branded content includes the Crypto Corner Podcast , Play by Play Sports Podcast , Cannabis News and Stocks on the Move Podcast ,  Cleantech and Climate Change Podcast,  Exploring Mining Podcast , Betting on Gaming Stocks Podcast and the AI Eye Podcast.  We also create free investor stock directories for AI and tech, biotech, cannabis, cleantech, crypto, defense, gaming, health and wellness, mining, oil and gas, sports and water.

Public companies within the sectors we cover can use our news publishing and content creation services to help tell their story to interested investors.

 

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. Disclosure: This tag article featuring NARA  is paid for content ( third party) Learn more about the cost of ticker tag articles and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

Follow us on Twitter https://twitter.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

 

Contact Investorideas.com

800-665-0411

 

Get more tech stocks investor ideas- news, articles, podcasts and stock directories

 

 

 

Get the Health, Wellness and Sustainability Stocks Directory at Investorideas.com - includes vegan and plant-based food stocks

 

 

Posted by at No comments:

Wednesday, November 22, 2023

#AI and #MentalHealth #Stocks to Watch (CSE: $NARA.CN) (NASDAQ: $WAVD) (NYSE: $AMWL) (NASDAQ: $TALK) @pangenomic @Amwell @talkspace

#AI and #MentalHealth #Stocks to Watch (CSE: $NARA.CN) (NASDAQ: $WAVD) (NYSE: $AMWL) (NASDAQ: $TALK) @pangenomic @Amwell @talkspace

 

How Technology Can be a Game Changer in Mental Health Treatment and AI is Leading the Way  

 


November 21, 2023 - Investorideas.com (www.investorideas.com), a global investor news source covering health and wellness stocks releases a special report on breakthrough technologies for mental health, featuring PanGenomic Health Inc. (CSE: NARA) (AQSE: NARA). PanGenomic describes itself as ‘’Your smart tech partner in natural health’ and is using the power of AI to help revolutionize healing. 

 

Read this article, featuring NARA in full at https://www.investorideas.com/news/2023/technology/11221AI-Mental-Health.asp

 

The global mental wellness market is anticipated to grow from USD 145.83 billion to USD 280.52 billion in 10 years. The market will experience rapid growth due to the rising awareness about mental wellness, Major market players are investing extensive capital in developing therapies, drugs, medical devices, equipment, systems, and treatments based on research findings to cater to the growing mental wellness market.

 

Most medical experts agree we are in a global mental health crisis and it is only worsening. While some companies turn to traditional methods including pharmaceuticals to solve the growing problem, others are looking to revolutionize the way we treat mental health using technology, and AI is aiming to take the driver’s seat.

 

PanGenomic Health Inc. (CSE: NARA) (AQSE: NARA), a precision health company that has developed a self-care digital platform using AI recently announced that its subsidiary, MUJN Diagnostics Inc. has launched its BDNF (brain-derived neurotrophic factor) mental health biomarker health assessment service.

 

More significantly, it has completed its first sale of the point-of-care test marketed to health clinics in Canada.

 

From the news: MUJN Diagnostics Inc. is a wholly-owned subsidiary of PanGenomic Health Inc. and is focused on developing a decision support system for alternative healthcare providers. MUJN's Decision Support System is intended to include biomarker diagnostics, symptom and treatment tracking, and personalized health analytics, with the goal of empowering healthcare providers and their patients towards better outcomes.

 

"Our strategy is to continue to expand MUJN Diagnostic's health services beyond our initial Vitamin D assessments to include rapid in-clinic access to a panel of mental health patient point-of-care biomarker assessments", said Vincent Lum, CEO of MUJN Diagnostics and Co-Founder of PanGenomic Health. "Our newest product is the MUJN BDNF Biomarker assessment for mental health and wellness. Changes in BDNF levels provide important information for health practitioners when considering treatment options for patients with brain health concerns such as major depressive disorder."

 

From the news: Current clinical research on BDNF has found that:

 

BDNF plays a significant role in the survival and development as well as creation of new neurons. BDNF has been shown to be a critical regulator of neurocognitive functions and impairment of BDNF levels have been connected to a variety of mental health diseases.

 

Decrease in the expression of BDNF is seen in many neurological problems such as Depression, Alzheimer's, Parkinson's, Huntington's and bipolar disease.

 

BDNF serum levels are lower in patients with major depressive disorder compared with those in healthy controls. Pharmacological treatments often lead to an increase in BDNF levels, which correlates with an improvement in a patient's mental health condition.

 

PanGenomic’s current ‘product line  includes its  Nustasis AI Platform, MUJN Diagnostics, and the NARA and MindLeap consumer apps, all designed to complement conventional medicine, and simplify the path to better health.

 

According to a June press release; “The Company is planning to launch Conversational AI on the web based NARA platform by Q3, followed by a roll out on the NARA app by Q4 of this year.”

 

A new entry to the public market with an AI approach to mental health, WaveDancer, Inc. (NASDAQ: WAVD)  announced last week that it has entered into a definitive merger agreement with privately held, commercial-stage, medical technology company, Firefly Neuroscience, Inc. (“Firefly”), to combine the companies in an all-stock transaction. The combined company will focus on continuing to develop and commercialize Firefly’s Artificial Intelligence driven Brain Network Analytics (BNA™) platform, which was previously cleared by the U.S. Food and Drug Administration (“FDA”). Upon closing, which is currently expected in Q1-2024, the combined company is expected to operate under the name Firefly Neuroscience, Inc., and trade on the Nasdaq Capital Market.

 

Describing  Firefly’s Brain Network Analytics (BNA™) platform the news says, “BNA™ is an FDA-cleared, cloud-based, AI-powered platform used to objectively assess brain function by comparing patient electroencephalograms (EEGs) with a proprietary database of standardized, high-definition EEGs and behavioral data. BNA™ is used by psychiatrists and neurologists in the United States to support the diagnosis of mental illnesses and cognitive disorders; optimize treatment care pathways; and improve patient compliance to therapy. Real-world clinical use has shown that when BNA™ is used as part of patient management, patients showed improved response rates; enhanced therapy compliance; and reduced non-responder rates and need for medication switching.”

 

From the news: Jamie Benoit, Chief Executive Officer and Chairman of WaveDancer, commented, “Following a strategic review and analysis of our long-term prospects as a publicly-traded company, the Board determined that this merger is in the best interests of WaveDancer’s stockholders and an attractive opportunity to realize significant value as Firefly pursues multiple market opportunities for its BNA™ platform. Firefly has emerged from the rigorous FDA approval process and its BNA™ platform has been subjected to comprehensive academic peer-review. We believe these factors contribute to a competitive advantage for Firefly and position it as a unique public company.”

 

Harnessing the power of AI for mental health improvement, Virtual care provider Amwell (NYSE: AMWL) as reported by Behavioral Health ”has its sights set on using artificial intelligence to bolster its behavioral health capabilities.”

 

“The telehealth giant recently launched a system within its platform that immediately connects patients to a therapist in real time.”

 

“After Amwell providers or its AI-backed automated systems determine the patient needs mental health services, the patient is queued to see a clinician on the same platform. The move is meant to bridge a systemic gap in health care: patient activation.”

 

“Amwell rolled out the system near the beginning of the quarter. It’s part of the company’s rolling implementation of Converge, a unified tech platform.”

 

“Survey data show that about 42% of Americans who sought mental health care couldn’t get it because of costs or other barriers, such as lack of proximity to care. This is a dire roadblock that keeps patients from getting the care they seek, or that is prescribed to them by primary care providers, who already have access to the patient.”

 

Also using technology for mental health, Talkspace (Nasdaq: TALK) a leading virtual behavioral healthcare company recently reported third quarter 2023 financial results.

 

Third Quarter 2023 Key Performance Metrics:

 

Revenue increased 32% over the prior-year period to $38.6 million, driven by a 79% year-over-year increase in the B2B revenue categories, partially offset by a 32% year-over-year consumer revenue decline.

 

Gross profit increased 29% over the prior-year period to $18.8 million, and gross margin declined to 48.8% from 49.8% year-over-year, driven by a shift in revenue mix towards payor.

Operating expenses were $24.0 million, down 30% year-over-year, driven by a reduction across all of our operating cost categories.

 

Net loss was $(4.4) million, an improvement from $(18.0) million net loss in the third quarter of 2022, primarily driven by lower operating expenses and an increase in revenues.

 

Talkspace pioneered the ability to text with a licensed therapist from anywhere and now offers a comprehensive suite of mental health services from self-guided products to individual and couples therapy, in addition to psychiatric treatment and medication management. With Talkspace’s core psychotherapy offering, members are matched with one of thousands of licensed providers across all 50 states and can choose from a variety of subscription plans including live video, text or audio chat sessions and/or asynchronous text messaging.

 

As technology evolves, the applications for health and wellness are endless. As PanGenomic Health says – AI and other technology may become natural health’s ‘smart tech partner’ of the future.

 

About Investorideas.com - Big Investing Ideas

Investorideas.com is a platform for investing ideas. We publish breaking stock news, stock research, guest posts and create original top rated investing podcasts, plus sector tag articles featuring up and coming companies and industry leaders.  Investor Idea’s original branded content includes the Crypto Corner Podcast , Play by Play Sports Podcast , Cannabis News and Stocks on the Move Podcast ,  Cleantech and Climate Change Podcast,  Exploring Mining Podcast , Betting on Gaming Stocks Podcast and the AI Eye Podcast.  We also create free investor stock directories for AI and tech, biotech, cannabis, cleantech, crypto, defense, gaming, health and wellness, mining, oil and gas, sports and water.

Public companies within the sectors we cover can use our news publishing and content creation services to help tell their story to interested investors.

 

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. Disclosure: This tag article featuring NARA  is paid for content ( third party) Learn more about the cost of ticker tag articles and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

Follow us on Twitter https://twitter.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

 

Contact Investorideas.com

800-665-0411

 


Get more tech stocks investor ideas- news, articles, podcasts and stock directories

 

 

  


Get the Health, Wellness and Sustainability Stocks Directory at Investorideas.com - includes vegan and plant-based food stocks

 

Posted by at No comments:
Subscribe to: Comments (Atom)